Free EU-Wide Shipping on Orders Over €200
This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals.
BPC-157
40,00 €
BPC-157 is a synthetic pentadecapeptide derived from human gastric juice. Extensively researched for tissue repair, wound healing, and cytoprotective properties. 10mg lyophilized powder, ≥99% purity.
Bulk Discounts
- Buy 3+ for 38,00 € each and save 5%
- Buy 5+ for 36,00 € each and save 10%
- Buy 10+ for 34,00 € each and save 15%
Ships Tomorrow - order cutoff passed
Free EU Shipping on orders over €200
Third party tested
BPC-157—
40,00 €
Advanced Laboratory Testing
HPLC
Mass Spec
≥99% Purity
Secure
Fast Ship
EU Based
Characteristics
| Molecular Formula | C62H98N16O22 |
| CAS | 137525-51-0 |
| Molar Mass | 1419.53 g/mol |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Synonyms | Body Protection Compound-157, PL 14736, PL-10 |
| Solubility | Soluble in water |
| Organoleptic Profile | White powder |
| Physical Form | Lyophilized powder |
How does BPC-157 work?
BPC-157 promotes angiogenesis (formation of new blood vessels) and accelerates healing of tendons, muscles, nerves, and ligaments. It modulates growth hormone receptor expression and enhances nitric oxide synthesis.
The peptide stabilizes gastric mucosa and promotes GI tract healing. Research indicates it influences the FAK-paxillin signaling cascade, which is central to cell migration and tissue remodeling.
BPC-157 demonstrates remarkable stability in gastric conditions, distinguishing it from many other bioactive peptides. This stability has made it valuable for studying gastrointestinal function, connective tissue biology, and regenerative processes.
References
- 1Sikirić P, et al. "Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications" Current Neuropharmacology. 2016. doi:10.2174/1570159X13666160502153022
- 2Vukojevic J, et al. "Rat inferior caval vein (ICV) syndrome, ICV-Loss and BPC 157" Current Pharmaceutical Design. 2020. doi:10.2174/1381612826666200127154113
- 3Seiwerth S, et al. "BPC 157 and Standard Angiogenic Growth Factors" Life Sciences. 2018. doi:10.1016/j.lfs.2018.08.045
Resource
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration or the European Medicines Agency. Products are not intended to diagnose, treat, cure, or prevent any disease.
